IMIC(SZ:000516)2023-10-26 16:00Financial Performance - Total operating revenue for the current period reached ¥3,343,661,725.08, a 74.70% increase compared to ¥1,913,897,141.34 in the same period last year[44]. - Net profit attributable to shareholders of the parent company was -¥222,323,554.29, improving by 73.12% from -¥827,089,125.83 year-on-year[45]. - Basic earnings per share improved to -¥0.0983 from -¥0.3634, reflecting a 72.95% increase[45]. - The company experienced a gross loss of ¥276,541,055.82, an improvement from a loss of ¥844,797,210.13 in the previous year[44]. - The diluted earnings per share improved to -¥0.0829 from -¥0.2933, marking a 71.74% increase[51]. - The weighted average return on net assets was reported at 0.00%, an improvement from -5.33% in the previous year[51]. Cash Flow - Cash inflow from operating activities totaled approximately RMB 3.27 billion, compared to RMB 2.11 billion in the previous period, reflecting a significant increase[29]. - Cash outflow from operating activities was approximately RMB 2.58 billion, compared to RMB 2.12 billion in the previous period[29]. - Net cash flow from operating activities was approximately RMB 689.15 million, a turnaround from a negative cash flow of RMB 2.80 million in the previous period[29]. - The company reported a net cash flow from operating activities of ¥689,153,979.24, a significant increase of 24,680.73% compared to the previous year[51]. - Year-to-date net cash flow from operating activities increased by 24,680.73% compared to the same period last year, primarily due to increased cash received from sales of goods and services[54]. - The net cash flow from financing activities was -469,134,181.46, a significant decrease from 46,620,668.65 in the previous period[30]. - Year-to-date net cash flow from financing activities decreased by 1,106.28% compared to the same period last year, primarily due to increased cash payments for debt repayment by the subsidiary Xi'an International Medical Center Co., Ltd.[54]. Assets and Liabilities - Total assets amounted to 11,115,603,256.35, a decrease from 13,264,224,493.51 in the previous period[41]. - The company reported a total of 1,838,387,664.75 in current assets, down from 3,711,899,394.23[41]. - The company's cash and cash equivalents at the end of the period stood at 786,874,951.16, down from 1,178,232,904.49 at the beginning of the year[41]. - Cash and cash equivalents decreased by 33.22% compared to the end of the previous year, primarily due to debt repayment by the subsidiary Xi'an International Medical Center Co., Ltd.[35]. - The company's total liabilities increased, impacting the overall financial position[41]. - Total liabilities decreased from 9,013,410,369.95 to 7,117,140,379.34, reflecting a significant reduction in overall debt levels[61]. Operating Costs and Expenses - The company's total operating costs for the current period were ¥3,731,857,156.74, up from ¥2,713,905,628.44, indicating a significant increase in expenses[44]. - Year-to-date selling expenses increased by 81.85% compared to the same period last year, mainly due to increased promotional expenses[54]. - Research and development expenses were reported at ¥9,533,885.43, slightly up from ¥9,456,290.06 in the previous period[44]. - Tax expenses increased by 158.54% year-to-date compared to the same period last year, primarily due to increased property tax from the subsidiary Xi'an International Medical Center Co., Ltd.[54]. Investments and Disposals - The company completed the sale of its equity in Shangluo International Medical Center Hospital Co., Ltd., which is expected to positively impact the company's asset structure and profitability[21]. - The company sold 99% of its stake in Shangluo International Medical Center Hospital Co., Ltd. for 170 million yuan[39]. - Year-to-date investment income increased by 939.04% compared to the same period last year, mainly due to gains from the sale of equity in the subsidiary Shangluo International Medical Center Hospital Co., Ltd.[54]. - The total amount of non-current asset disposal gains and losses was 118,942,238.02 for the current reporting period[34]. Current Assets and Receivables - Accounts receivable increased by 75.64% compared to the end of the previous year, primarily due to increased medical insurance settlement receivables from the subsidiary Xi'an International Medical Center Co., Ltd.[18]. - Prepayments increased by 56.35% compared to the end of the previous year, mainly due to increased operating expense prepayments from the subsidiary Xi'an International Medical Center Co., Ltd.[18]. - Inventory increased by 32.22% compared to the end of the previous year, primarily due to increased drug stockpiling by subsidiaries Xi'an Gaoxin Hospital Co., Ltd. and Xi'an International Medical Center Co., Ltd.[18]. - Other current assets increased by 78.70% compared to the end of the previous year, mainly due to increased deductible input tax receivables from the subsidiary Xi'an International Rehabilitation Medical Center Co., Ltd.[18]. Fixed Assets and Construction - Fixed assets increased by 36.27% compared to the end of the previous year, while construction in progress decreased by 95.87%, primarily due to the transfer of estimated construction projects to fixed assets by the subsidiary Xi'an International Rehabilitation Medical Center Co., Ltd.[18]. - The company’s fixed assets increased to 7,746,999,709.05 from 5,684,908,536.84 in the previous period[41]. - Non-current liabilities due within one year increased by 44.06% compared to the end of the previous year, primarily due to the increase in long-term borrowings of the subsidiary Xi'an International Medical Center Co., Ltd.[54].